Cargando…
Antiangiogenesis in recurrent glioblastoma: proof of principle
Glioblastoma multiforme, a neoplasm with variable histological and biological features, is characterized by diverse imaging features, including highly heterogeneous enhancement. This reflects variable disruption of the blood brain barrier and inherent differences in the vascularity of the tumor. Exp...
Autores principales: | Nossek, Erez, Ram, Zvi, Bokstein, Felix, Blumenthal, Deborah |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3093229/ https://www.ncbi.nlm.nih.gov/pubmed/21577359 http://dx.doi.org/10.4081/ni.2009.e21 |
Ejemplares similares
-
Concurrent Tumor Treating Fields (TTFields) and Radiation Therapy for Newly Diagnosed Glioblastoma: A Prospective Safety and Feasibility Study
por: Bokstein, Felix, et al.
Publicado: (2020) -
Monitoring antiangiogenesis of bevacizumab in zebrafish
por: Zhang, Jing, et al.
Publicado: (2018) -
Proof of principle for bevacizumab activity in desmoid-type fibromatosis
por: Grünwald, Viktor, et al.
Publicado: (2016) -
Surrogate markers in antiangiogenesis clinical trials
por: Davis, D W, et al.
Publicado: (2003) -
Microbiome Crosstalk in Immunotherapy and Antiangiogenesis Therapy
por: Wan, Xueting, et al.
Publicado: (2021)